
Blood clots linked to AstraZeneca vaccine stem from rare antibody reaction
Scientific teams from Germany and Norway found that people who developed the clots after vaccination had produced antibodies that activated their platelets, a blood component involved in clotting. The new reports add extensive details to what the …